Shares of Keurig Dr Pepper Inc (NYSE:KDP) have been given an average rating of “Hold” by the sixteen research firms that are currently covering the stock, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a sell recommendation, five have given a hold recommendation and nine have given a buy recommendation to the company. The average 1 year target price among analysts that have issued ratings on the stock in the last year is $30.27.
A number of brokerages have commented on KDP. BMO Capital Markets upgraded Keurig Dr Pepper from a “market perform” rating to an “outperform” rating and lifted their target price for the company from $27.00 to $34.00 in a research note on Monday, June 17th. Zacks Investment Research upgraded shares of Keurig Dr Pepper from a “hold” rating to a “buy” rating and set a $32.00 price objective for the company in a report on Wednesday, June 19th. ValuEngine upgraded shares of Keurig Dr Pepper from a “strong sell” rating to a “sell” rating in a report on Thursday. Morgan Stanley set a $24.00 price objective on shares of Keurig Dr Pepper and gave the stock a “sell” rating in a report on Friday, August 9th. Finally, Credit Suisse Group started coverage on shares of Keurig Dr Pepper in a report on Wednesday, July 17th. They issued a “neutral” rating and a $27.00 price objective for the company.
Shares of KDP stock traded down $0.41 on Wednesday, reaching $27.40. 2,929,046 shares of the stock were exchanged, compared to its average volume of 2,558,292. The company has a current ratio of 0.33, a quick ratio of 0.23 and a debt-to-equity ratio of 0.58. The business’s 50 day moving average price is $27.22 and its 200 day moving average price is $28.15. The company has a market capitalization of $38.88 billion, a price-to-earnings ratio of 26.35, a PEG ratio of 1.48 and a beta of 0.46. Keurig Dr Pepper has a twelve month low of $22.95 and a twelve month high of $31.06.
Keurig Dr Pepper (NYSE:KDP) last issued its earnings results on Thursday, August 8th. The company reported $0.30 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.29 by $0.01. The company had revenue of $2.81 billion during the quarter, compared to analysts’ expectations of $2.86 billion. Keurig Dr Pepper had a net margin of 8.82% and a return on equity of 7.15%. The firm’s quarterly revenue was up 196.3% compared to the same quarter last year. During the same period last year, the company posted $1.30 earnings per share. Equities research analysts forecast that Keurig Dr Pepper will post 1.22 earnings per share for the current year.
The company also recently announced a quarterly dividend, which will be paid on Friday, October 18th. Shareholders of record on Friday, October 4th will be given a dividend of $0.15 per share. This represents a $0.60 dividend on an annualized basis and a yield of 2.19%. The ex-dividend date of this dividend is Thursday, October 3rd. Keurig Dr Pepper’s dividend payout ratio is 57.69%.
In other news, insider Mary Beth Denooyer bought 6,000 shares of the business’s stock in a transaction on Tuesday, August 20th. The stock was purchased at an average price of $27.99 per share, with a total value of $167,940.00. The acquisition was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Robert S. Singer acquired 3,000 shares of the business’s stock in a transaction dated Tuesday, August 13th. The shares were bought at an average cost of $28.65 per share, with a total value of $85,950.00. The disclosure for this purchase can be found here. In the last three months, insiders have acquired 80,727 shares of company stock valued at $1,937,641. Company insiders own 0.44% of the company’s stock.
Several institutional investors and hedge funds have recently made changes to their positions in KDP. Raymond James Financial Services Advisors Inc. raised its position in shares of Keurig Dr Pepper by 69.7% during the first quarter. Raymond James Financial Services Advisors Inc. now owns 21,922 shares of the company’s stock valued at $613,000 after buying an additional 9,007 shares during the last quarter. Great West Life Assurance Co. Can raised its position in shares of Keurig Dr Pepper by 3.3% during the first quarter. Great West Life Assurance Co. Can now owns 41,548 shares of the company’s stock valued at $1,156,000 after buying an additional 1,310 shares during the last quarter. First Trust Advisors LP raised its position in shares of Keurig Dr Pepper by 3.0% during the first quarter. First Trust Advisors LP now owns 712,912 shares of the company’s stock valued at $19,940,000 after buying an additional 20,641 shares during the last quarter. AJO LP acquired a new position in shares of Keurig Dr Pepper during the first quarter valued at about $435,000. Finally, Xact Kapitalforvaltning AB acquired a new position in shares of Keurig Dr Pepper during the first quarter valued at about $432,000. 19.53% of the stock is owned by institutional investors and hedge funds.
Keurig Dr Pepper Company Profile
Keurig Dr Pepper Inc operates as a beverage company in the United States and internationally. It operates through four segments: Beverage Concentrates, Packaged Beverages, Latin America Beverages, and Coffee Systems. The Beverage Concentrates segment manufactures and sells beverage concentrates. This segment also manufactures beverage concentrates into syrup.
Featured Article: Support Level
Receive News & Ratings for Keurig Dr Pepper Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Keurig Dr Pepper and related companies with MarketBeat.com's FREE daily email newsletter.